Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and abt-770

levofloxacin has been researched along with abt-770 in 2 studies

Compound Research Comparison

Studies
(levofloxacin)		Trials
(levofloxacin)		Recent Studies (post-2010)
(levofloxacin)		Studies
(abt-770)		Trials
(abt-770)		Recent Studies (post-2010) (abt-770)
4,3465812,209601

Protein Interaction Comparison

ProteinTaxonomylevofloxacin (IC50)abt-770 (IC50)
Interstitial collagenaseHomo sapiens (human)4.6
72 kDa type IV collagenaseHomo sapiens (human)0.004
Stromelysin-1Homo sapiens (human)0.042
Matrix metalloproteinase-9Homo sapiens (human)0.12

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Glen, RC; Lowe, R; Mitchell, JB1

Other Studies

2 other study(ies) available for levofloxacin and abt-770

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010